Literature DB >> 32732830

Uncontrolled Donation After Circulatory Death: A Unique Opportunity.

Elisabeth Coll1, Eduardo Miñambres2, Ana Sánchez-Fructuoso3, Constantino Fondevila4, José Luis Campo-Cañaveral de la Cruz5, Beatriz Domínguez-Gil1.   

Abstract

Uncontrolled donation after circulatory death (uDCD) refers to donation from persons who die following an unexpected and unsuccessfully resuscitated cardiac arrest. Despite the large potential for uDCD, programs of this kind only exist in a reduced number of countries with a limited activity. Barriers to uDCD are of a logistical and ethical-legal nature, as well as arising from the lack of confidence in the results of transplants from uDCD donors. The procedure needs to be designed to reduce and limit the impact of the prolonged warm ischemia inherent to the uDCD process, and to deal with the ethical issues that this practice poses: termination of advanced cardiopulmonary resuscitation, extension of advanced cardiopulmonary resuscitation beyond futility for organ preservation, moment to approach families to discuss donation opportunities, criteria for the determination of death, or the use of normothermic regional perfusion for the in situ preservation of organs. Although the incidence of primary nonfunction and delayed graft function is higher with organs obtained from uDCD donors, overall patient and graft survival is acceptable in kidney, liver, and lung transplantation, with a proper selection and management of both donors and recipients. Normothermic regional perfusion has shown to be critical to achieve optimal outcomes in uDCD kidney and liver transplantation. However, the role of ex situ preservation with machine perfusion is still to be elucidated. uDCD is a unique opportunity to improve patient access to transplantation therapies and to offer more patients the chance to donate organs after death, if this is consistent with their wishes and values.

Entities:  

Mesh:

Year:  2020        PMID: 32732830     DOI: 10.1097/TP.0000000000003139

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  Donation after circulatory death and lung transplantation.

Authors:  Pedro Augusto Reck Dos Santos; Paulo José Zimermann Teixeira; Daniel Messias de Moraes Neto; Marcelo Cypel
Journal:  J Bras Pneumol       Date:  2022-04-20       Impact factor: 2.800

2.  [Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19)].

Authors:  M Á Ballesteros Sanz; A Hernández-Tejedor; Á Estella; J J Jiménez Rivera; F J González de Molina Ortiz; A Sandiumenge Camps; P Vidal Cortés; C de Haro; E Aguilar Alonso; L Bordejé Laguna; I García Sáez; M Bodí; M García Sánchez; M J Párraga Ramírez; R M Alcaraz Peñarrocha; R Amézaga Menéndez; P Burgueño Laguía
Journal:  Med Intensiva (Engl Ed)       Date:  2020-04-08

Review 3.  Donation after circulatory death donors in lung transplantation.

Authors:  Thomas M Egan; Benjamin E Haithcock; Jason Lobo; Gita Mody; Robert B Love; John Jacob Requard; John Espey; Mir Hasnain Ali
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 3.005

4.  Program of Uncontrolled Donation After Circulatory Death as Potential Solution to the Shortage of Organs: A Canadian Single-Center Retrospective Cohort Study.

Authors:  Frederick D'Aragon; Olivier Lachance; Vincent Lafleur; Ivan Ortega-Deballon; Marie-Helene Masse; Gabrielle Trepanier; Daphnee Lamarche; Marie-Claude Battista
Journal:  Open Access Emerg Med       Date:  2022-08-05

Review 5.  COVID-19 in Spain: Transplantation in the midst of the pandemic.

Authors:  Beatriz Domínguez-Gil; Elisabeth Coll; Mario Fernández-Ruiz; Esther Corral; Francisco Del Río; Rafael Zaragoza; Juan J Rubio; Domingo Hernández
Journal:  Am J Transplant       Date:  2020-05-27       Impact factor: 9.369

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.